Format

Send to

Choose Destination
J Biomed Mater Res A. 2015 Oct;103(10):3331-8. doi: 10.1002/jbm.a.35478. Epub 2015 Apr 30.

Degradable hydrogels derived from PEG-diacrylamide for hepatic tissue engineering.

Author information

1
Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139.
2
Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, 19104.
3
Howard Hughes Medical Institute, Cambridge, Massachusetts, 02139.
4
Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139.

Abstract

Engineered tissue constructs have the potential to augment or replace whole organ transplantation for the treatment of liver failure. Poly(ethylene glycol) (PEG)-based systems are particularly promising for the construction of engineered liver tissue due to their biocompatibility and amenability to modular addition of bioactive factors. To date, primary hepatocytes have been successfully encapsulated in non-degradable hydrogels based on PEG-diacrylate (PEGDA). In this study, we describe a hydrogel system based on PEG-diacrylamide (PEGDAAm) containing matrix-metalloproteinase sensitive (MMP-sensitive) peptide in the hydrogel backbone that is suitable for hepatocyte culture both in vitro and after implantation. By replacing hydrolytically unstable esters in PEGDA with amides in PEGDAAm, resultant hydrogels resisted non-specific hydrolysis, while still allowing for MMP-mediated hydrogel degradation. Optimization of polymerization conditions, hepatocellular density, and multicellular tissue composition modulated both the magnitude and longevity of hepatic function in vitro. Importantly, hepatic PEGDAAm-based tissues survived and functioned for over 3 weeks after implantation ectopically in the intraperitoneal (IP) space of nude mice. Together, these studies suggest that MMP-sensitive PEGDAAm-based hydrogels may be a useful material system for applications in tissue engineering and regenerative medicine.

KEYWORDS:

PEGDAAm; liver; matrix metalloproteinase; polyethylene glycol diacrylamide; tissue engineering

PMID:
25851120
PMCID:
PMC4890565
DOI:
10.1002/jbm.a.35478
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center